Bloomberg - Oct. 18 (Bloomberg) -- Gilead Sciences Inc., the largest maker of HIV drugs in the U.S., said third-quarter sales climbed 41 percent as demand increased for therapies that allow AIDS patients to take fewer pills a day. Net income was $398.3 million ...
